Postoperative Analgesic efficacy of continuous wound INfusion after laparoscopy (PAIN): a randomized, double-blind, placebo-controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003439

Enrollment

Registered

2019-01-21

Start date

2019-01-07

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Continuous wound infusion device used in this study was ON-Q Painbuster Silver Soaker (I-Flow Corporation, Lake Forest, CA, USA) comprised an elastomeric pump maintaining constant pre

) in participants allocated in the CWI group, while it filled with 100ml of 0.9&#37

saline in participants allocated in the placebo group.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: - age between 18 and 65 years, - American Society of Anesthesiologists physical status (ASAPS) classification I–II, - absence of pregnancy at the time of surgery

Exclusion criteria

Exclusion criteria: - allergy to ropivacaine, - laparoscopic surgery needing = 3 separate skin incisions, - history of ventral or incisional hernia, pre-existing coagulopathy, neurologic or cognitive dysfunction, - systemic or regional (especially, umbilicus) infection, - previously taking opioids for chronic pain, or - inability to accurately express their pain.

Design outcomes

Primary

Measure	Time frame
the severity of postoperative pain	—

Secondary

Measure	Time frame
the degree of postoperative nausea and vomiting (PONV)	—

Countries

Korea, Republic of

Contacts

Public ContactTaejong Song

Kangbuk Samsung Medical Center

taejong.song@gmail.com+82-2-2001-2052

Outcome results